Key Points Interested in Incyte Corporation? Here are five stocks we like better. Incyte plans to start a Phase 3 trial of ...

Incyte Corporation ( NASDAQ:INCY ) announced strong profits, but the stock was stagnant. Our analysis suggests ...

Incyte Corp (INCY) reports a robust start to 2026 with a 21% revenue increase and advances in its late-stage pipeline, despite challenges in diversifying beyond Jakafi.

Feb 10 (Reuters) - Incyte Corp (INCY.O), opens new tab on Monday forecast annual sales of its skin disorder treatment Opzelura below Wall Street estimates, sending the drugmaker's shares down as much ...

We recently compiled a list of the 15 Best Biotech Stocks to Buy According to Billionaires. In this article, we are going to ...

We recently published Wall Street Can’t Keep up With These 10 Crushing Stocks; 6 at Fresh Record Highs. Incyte Corp. (NASDAQ:INCY) is one of the best-performing on Monday. Incyte extended its winning ...

Bank of America Global Healthcare Conference 2026 May 13, 2026 4:40 PM EDTCompany ParticipantsWilliam Meury - CEO ...

April 29 (Reuters) - Incyte Corp (INCY.O), opens new tab raised the annual sales forecast for its blood cancer drug Jakafi on Tuesday, and said it expects minimal impact from U.S. tariffs due to its ...

Incyte Corporation (NASDAQ:INCY) ranks among the most profitable biotech stocks to buy now. On April 15, H.C. Wainwright restated Incyte Corporation (NASDAQ:INCY)’s Buy rating and $135 price target.

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Hi. Welcome, everyone, to this session of the Morgan Stanley Global Healthcare Conference. We're thrilled to have the Incyte team with us represented by Bill and Dr. Steven Stein. I'm Judah Frommer, ...

Sun Pharmaceutical Industries was hit with a patent infringement lawsuit on July 11 in New Jersey District Court. The action, brought by Saul Ewing and Patterson Belknap Webb & Tyler on behalf of ...